Regenicin Inc (RGIN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Regenicin Inc (RGIN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7901
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tissue-engineered skin for the treatment of severe burns. Regenicin offers banked allogenic cell products for treatment of chronic wounds, cosmetic and other topical testing, and medical testing services. The company develops products for diabetes and chronic wounds including ulcers, adult stem cell therapies and reconstructive surgical applications. It has operations throughout the US. Regenicin is headquartered in Little Falls, New Jersey, the US.

Regenicin Inc (RGIN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regenicin Inc, Medical Equipment, Deal Details 10
Debt Offering 10
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 10
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 11
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 12
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 14
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 15
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 17
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 18
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 19
Regenicin Inc – Key Competitors 20
Regenicin Inc – Key Employees 21
Regenicin Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Jan 18, 2017: Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Regenicin Inc, Medical Equipment, Key Facts, 2017 2
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Deals By Market, 2012 to YTD 2018 8
Regenicin Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 10
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 11
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 12
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 14
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 15
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 17
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 18
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 19
Regenicin Inc, Key Competitors 20
Regenicin Inc, Key Employees 21
Regenicin Inc, Subsidiaries 22

List of Figures
Regenicin Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Regenicin Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Regenicin Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Regenicin Inc (RGIN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Engie Brasil Energia SA (EGIE3):企業の財務・戦略的SWOT分析
    Engie Brasil Energia SA (EGIE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • West Hertfordshire Hospitals NHS Trust:企業の戦略的SWOT分析
    West Hertfordshire Hospitals NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Voltamp Energy SAOG (VOES):企業の財務・戦略的SWOT分析
    Voltamp Energy SAOG (VOES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • East Central Energy:企業の発電所・SWOT分析2018
    East Central Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, is a clinical stage biopharmaceutical company which discovers and develops targeted cancer immunotherapies. The company’s pipeline product candidates include AFM11, AFM12, AFM13, AFM21 and AFM22, among othe …
  • IO Biotech ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines. The company developed a pipeline of first-in-class anti-cancer drugs harnessing a unique technology platform, T-Win. IO Biotech's immuno-oncology therapie …
  • Pharmaxis Ltd (PXS):企業の財務・戦略的SWOT分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Intelligent InSites Inc-医療機器分野:企業M&A・提携分析
    Summary Intelligent InSites Inc (Insites) is a healthcare technology company that provides technology services and automation solutions for health care organizations. The company offers implantation, training, technical support, product maintenance and solution services. Its solution include additio …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Hal Trust
    Hal Trust - Strategy, SWOT and Corporate Finance Report Summary Hal Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Famous Brands Limited (Foodservice):企業の戦略・SWOT・財務情報
    Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Sodexo Inc:企業の戦略的SWOT分析
    Sodexo Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Zimplats Holdings Ltd:企業の戦略・SWOT・財務分析
    Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Zimplats Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nakheel
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Asseco Poland SA (ACP):企業の財務・戦略的SWOT分析
    Summary Asseco Poland SA (Asseco) is a technology company that offers information processing solutions. The company offers banking, insurance companies, public institutions, healthcare, telecommunication, utilities, ERP solutions, IT infrastructure and others. Its IT infrastructure solutions include …
  • Glen Dimplex Group:企業の戦略的SWOT分析
    Glen Dimplex Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Etam Developpement SCA:戦略・SWOT・企業財務分析
    Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report Summary Etam Developpement SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆